在患有1型和2型糖尿病的年轻成年人中,医疗保健利用率和结果
Anna Zenno1,2, Alyssa Huang1, Alissa J Roberts1
1Department of Pediatrics, University of Washington, Seattle, WA 98105, USA.
Journal of the Endocrine Society
|June 28, 2024
概括
患有糖尿病的年轻人面临着自我护理方面的挑战,导致HbA1c水平升高和医疗保健使用增加. 了解这些因素对于改善这种年龄段糖尿病管理至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
- 医疗保健管理的管理
背景情况:
- 由于生活过渡和独立性增加,年轻成年期对糖尿病 (DM) 自主管理提出了独特的挑战.
- 与老年人相比,患有DM的年轻人表现出较差的血糖控制 (较高的HbA1c) 和较低的护理标准遵守.
- 这种人口群体的急诊室访问和住院率更高,通常是糖尿病酸性脂肪酸症.
研究的目的:
- 审查患有DM的年轻成年人中医疗保健利用模式.
- 探索导致该群体HbA1c水平升高的因素.
- 讨论特定的医疗保健需求,技术作用和影响DM年轻成年人的健康的社会决定因素.
主要方法:
- 这项研究是对现有的关于医疗保健利用和年轻成年人DM管理的文献的综述.
- 它综合了影响血糖控制,自我护理遵守和健康结果的因素信息.
- 该审查分析了技术和健康的社会决定因素对医疗保健获取和利用的影响.
主要成果:
- 患有DM的年轻人表现出明显的医疗保健利用模式,通常以更高的紧急护理需求为标志.
- 导致低于最佳的血糖控制的因素包括自我护理方面的挑战,坚持问题和社会经济影响.
- 技术采用和社会决定因素对这一群体的医疗保健经验和结果产生了重大影响.
结论:
- 解决患有DM的年轻成年人的独特需求需要定制的干预措施,重点是自我护理支持和坚持.
- 整合技术解决方案和减轻社会决定因素的影响对于改善健康结果至关重要.
- 加强医疗保健策略是必要的,以减少并发症,并改善年轻人管理糖尿病的长期健康.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Carbohydrate Metabolism
11.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.0K
Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Insulin: Dosing Regimen and Adverse Effects
165
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
165


